| Tag | Content |
|---|
EnhancerAtlas ID | HS034-17019 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr2:113835560-113837060 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| GFI1 | MA0038.2 | chr2:113835969-113835981 | TGCTGTGATTTC | - | 6.22 | | Gfi1b | MA0483.1 | chr2:113835969-113835980 | TGCTGTGATTT | - | 6.62 | | TCF3 | MA0522.2 | chr2:113835575-113835585 | AGCAGGTGTT | - | 6.02 | | ZNF263 | MA0528.1 | chr2:113835913-113835934 | CCCTCCCCTTCTCCCTCCCTG | - | 6.03 | | ZNF263 | MA0528.1 | chr2:113835906-113835927 | ACCCCCTCCCTCCCCTTCTCC | - | 6.81 | | ZNF263 | MA0528.1 | chr2:113835909-113835930 | CCCTCCCTCCCCTTCTCCCTC | - | 7.19 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_26693 | chr2:113834343-113836231 | Esophagus | | SE_26693 | chr2:113836267-113839903 | Esophagus |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr2 | 113835950 | 113836479 | | chr2 | 113835949 | 113836406 | | chr2 | 113835577 | 113835744 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I113076 | chr2 | 113834552 | 113838205 |
|
Enhancer Sequence | GGGCCTCAGA GAAAAAGCAG GTGTTTTCCA GGCAGAGAAC GCAGGGATGG GCATCCCAGG 60
CAGAAAAACT GCTCAGGAAG GTGTGATGAT GGAGAAGAGC TCCCAGCACA TCTGAGGTGA 120
GTCATCAATG TGGCTGGGAC CCAGGGCTTG GACTGAGGAG TGGCTGCAAA TTCACATGAG 180
AAGATGGGTG GCTCCTGATT GCTAATGCCT TGTGAAGGAG TTTTTATCTG GGAGGCCCCA 240
AGGAATCATC CAGGTATTTC AGGCAGGACC CAGATTTTAA TCCTGGGCCC CTCAGATCAG 300
CACTGGGCCA ACACAGATGC TACTGGGTCC TCAGCTCTTC TCAGCCACCC CCTCCCTCCC 360
CTTCTCCCTC CCTGACTTCT GTTTAGCACT GCCCCGGGGT CAGCTTCCAT GCTGTGATTT 420
CACAGTCAGC CTGACCCCTG CTTCATCTTC CCTGACCAGT TCATCACCTT CATGCATGTG 480
TTGAAAGACA AACTTTGGCA TATTAAAATT TTAAGGAGTT TATTTGAGCA GAGAATGATT 540
CATGAATCAC AAGGTGCCAA ATTGCAAGTG ATTCAGGGCT CCACCCAGGG GCTACCGGAA 600
AACCATTTAT AAGTTGTTCA GGAAGCAAAA GGAAGAAAAA AATTCATTGG TTAAGTGGAA 660
AATCCTTAGT TGCAGGTTAG TCGGCGGTTC CTGATTGGCT AAGCTTAAGT TTCGTTTTCT 720
TAGTCAATGA CCATTCACTC TGGGTTGGGT TTTAGTTTAC TTAGGCAGGA ACCCAACACG 780
CTGGAGTCAT CTCAGCCTAA TACCTTCCCA ATTAATTATT TTAACACATG GTAACTCATT 840
TCTGCTGGCC CTTCCCTTGT GAACTGTGCC CATGGACCAC CCAGGCAAAT GCAGGCCTCC 900
TCCTACTTAC TAGTGGTGCT GTTCCAAGTT GAATCATGTT CTCTATATAA CTAAAAAAAA 960
TTTTCACATG TAAAATATGC CAATTCTCTA ACAGTGCACA GAAGAGGAAG AGGACATAAA 1020
GACTTAGAAG ACATGTCTCT ATGACTGAAG GACACATAGT GCAGATGGGA AAACCAGACC 1080
TTGTGAATAA AAGCTCATAT TTATTGACTG CAAGACACTC CAAATAGCAC TTAGAATCAA 1140
ATTCTGCAGG ACTGTGGTAG AAATAGTGAT GGGACTTTCT GGCACTAGGG TTTAAAAGTA 1200
AGGAATGGAG GCAATTTCTG ACAGGTGCAG TTCAGCGATG CCAAGAGTAT TCTTCTCCCA 1260
CGCCCCAAGG CTCATTCCTT AAATTCCTTC TCCTCCCTAG AAACCACACC AAAGTCTTCA 1320
CTCCAAAACC TAACCAGGCT AGAGGGTTAT TATTATGTGA ATTCTAGGGA GAGGTACACT 1380
TTAGGTCTTA TCCACTATTT ACATCTCAGA ATGAACTGGT AGGTCCAGAG AGAGAGCAAA 1440
CAGGCAATTA AACACAGTGT GGCCAGCTTT CGGTCAGGTA GCACCAGGAG CAGGGTGGGT 1500
|
